Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (71-80 of 393) with videos related to

Pageof 40
Sort By:
The Lancet. Oncology|September 2, 2022
Immune checkpoint inhibition in sarcomas: time to be histology-specific?Andrea Napolitano, Paul H Huang, Robin L Jones, et al.
NPJ Precision Oncology|March 6, 2021
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomasEve Merry, Khin Thway, Robin L Jones, et al.
Expert Review of Gastroenterology & Hepatology|January 16, 2023
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumorsAmalya Sargsyan, Monika A Kucharczyk, Robin L Jones, et al.
The Indian Journal of Medical Research|February 13, 2020
Ewing-like sarcomas: New molecular diagnoses in need of optimized treatment approachesAlex T J Lee, Paul H Huang, Robin L Jones
Expert Review of Anticancer Therapy|May 1, 2020
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtypeJavier Martín-Broto, Peter Reichardt, Robin L Jones, et al.
Future Oncology (London, England)|February 3, 2021
Extraskeletal osteosarcomas: current updateAbhay K Kattepur, Ashish Gulia, Robin L Jones, et al.
Signal Transduction and Targeted Therapy|May 25, 2019
Pazopanib in advanced soft tissue sarcomasAlex T J Lee, Robin L Jones, Paul H Huang
Journal of Women'S Health (2002)|May 25, 2012
Reducing maternal deaths through state maternal mortality reviewSarah J Kilpatrick, Patricia Prentice, Robin L Jones, et al.
Expert Review of Anticancer Therapy|November 25, 2021
Risk factors for the development of local recurrence in extremity soft-tissue sarcomaFabio Tirotta, Raza Sayyed, Robin L Jones, et al.
Current Opinion in Oncology|April 30, 2021
Next-generation sequencing for the management of sarcomas with no known driver mutationsSimon Vyse, Khin Thway, Paul H Huang, et al.
Pageof 40

Showing results (71-80 of 393) with videos related to

Sort By:
Pageof 40
The Lancet. Oncology|September 2, 2022
Immune checkpoint inhibition in sarcomas: time to be histology-specific?Andrea Napolitano, Paul H Huang, Robin L Jones, et al.
NPJ Precision Oncology|March 6, 2021
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomasEve Merry, Khin Thway, Robin L Jones, et al.
Expert Review of Gastroenterology & Hepatology|January 16, 2023
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumorsAmalya Sargsyan, Monika A Kucharczyk, Robin L Jones, et al.
The Indian Journal of Medical Research|February 13, 2020
Ewing-like sarcomas: New molecular diagnoses in need of optimized treatment approachesAlex T J Lee, Paul H Huang, Robin L Jones
Expert Review of Anticancer Therapy|May 1, 2020
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtypeJavier Martín-Broto, Peter Reichardt, Robin L Jones, et al.
Future Oncology (London, England)|February 3, 2021
Extraskeletal osteosarcomas: current updateAbhay K Kattepur, Ashish Gulia, Robin L Jones, et al.
Signal Transduction and Targeted Therapy|May 25, 2019
Pazopanib in advanced soft tissue sarcomasAlex T J Lee, Robin L Jones, Paul H Huang
Journal of Women'S Health (2002)|May 25, 2012
Reducing maternal deaths through state maternal mortality reviewSarah J Kilpatrick, Patricia Prentice, Robin L Jones, et al.
Expert Review of Anticancer Therapy|November 25, 2021
Risk factors for the development of local recurrence in extremity soft-tissue sarcomaFabio Tirotta, Raza Sayyed, Robin L Jones, et al.
Current Opinion in Oncology|April 30, 2021
Next-generation sequencing for the management of sarcomas with no known driver mutationsSimon Vyse, Khin Thway, Paul H Huang, et al.
Pageof 40